LG Chem, Ltd

Products

ESPOGEN Prefilled Inj.

    • Product Name: ESPOGEN Prefilled Inj.
    • Chemical Name (IUPAC): Epoetin alfa
    • CAS No.: 113427-24-0
    • Chemical Formula: C815H1317N233O241S4
    • Form/Physical State: Injection
    • Factroy Site:
    • Price Inquiry: sales6@ascent-chem.com
    • Manufacturer: LG Chem, Ltd
    • CONTACT NOW
    VTB
    Specifications
    HS Code 318734
    Brand Name ESPOGEN Prefilled Inj.
    Generic Name Epoetin alfa
    Formulation Prefilled Injection
    Route Of Administration Subcutaneous or intravenous
    Strength Varies (e.g., 2000 IU/0.5ml, 4000 IU/0.4ml, etc.)
    Therapeutic Class Erythropoiesis-stimulating agent
    Indication Anemia associated with chronic kidney disease, chemotherapy-induced anemia
    Manufacturer LG Chem
    Storage Conditions Refrigerate at 2°C to 8°C
    Prescription Status Prescription only
    Packaging Single-use prefilled syringe
    Country Of Origin South Korea

    As an accredited ESPOGEN Prefilled Inj. factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for **ESPOGEN Prefilled Inj.** contains 1 prefilled syringe, clearly labeled with dosage information and detailed usage instructions.
    Container Loading (20′ FCL) Container Loading (20′ FCL): ESPOGEN Prefilled Inj. is securely packed, maximizing space, ensuring temperature stability, and adhering to international shipping standards.
    Shipping **ESPOGEN Prefilled Inj.** requires cold chain shipping between 2°C and 8°C. The product must be packed in insulated containers with ice packs to maintain temperature stability. Avoid freezing. Ensure the package is tightly sealed, properly labeled as “Refrigerated,” and shipped via priority or express services to minimize transit time and ensure potency.
    Storage ESPOGEN Prefilled Injection should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect it from light by keeping it in its original packaging and do not freeze. Keep out of reach of children. Do not shake the prefilled syringe, and avoid using if the solution is discolored or contains visible particles.
    Shelf Life The shelf life of **ESPOGEN Prefilled Inj.** is 24 months when stored at 2°C to 8°C, protected from light.
    Application of ESPOGEN Prefilled Inj.

    Applications of ESPOGEN Prefilled Inj. in Industrial Manufacturing

    As the direct manufacturer, we provide ESPOGEN Prefilled Inj. to critical sectors where industrial users require batch-controlled, pharmacopoeia-grade materials for regulated downstream production. Below, we outline specific application routes with detailed process, compliance, and usage considerations in each real downstream industry.

    1. Biopharmaceuticals: Erythropoietin (EPO) Formulation

    Major pharmaceutical formulators use ESPOGEN Prefilled Inj. in sterile filling facilities to manufacture erythropoietin injection products. The material enters at final compounding after upstream EPO protein purification and must meet injectable-grade sterility and residual solvent criteria. Manufacturers adjust formulation depending on target dosing, excipient matrix, and storage stability needs for clinical and retail distribution. Quality teams follow strict lot traceability and serialization protocols for international regulatory submissions.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Hospital Compounding Centers: Ready-to-Use Injectable Preparations

    Large hospital compounding centers introduce ESPOGEN Prefilled Inj. directly for standardized preparation of injectable solutions tailored for acute anemia and kidney dialysis management. The material enables high-throughput, GMP-compliant batch compounding, meeting traceability and sterility requirements for use in central intravenous additive services (CIVAS). Pharmacy teams titrate final concentration according to patient-specific protocols, balancing hemoglobin targets and administration route.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Contract Manufacturing Organizations (CMO): Biosimilar Drug Production

    CMOs utilize ESPOGEN Prefilled Inj. for the development and fill-finish of biosimilar erythropoietin products under multinational licensing. They operate under rigorous QMS and adapt formulation and filling parameters to each client’s submission dossier. Integration of prefilled systems supports process validation and commercial scaleup while ensuring equivalency testing against reference biologics for both domestic and export submissions.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Blood Product Manufacturing: Quality Control Reagents

    Specialty blood banking suppliers use ESPOGEN Prefilled Inj. as a standardized reference material in batch calibration and routine QC testing for automated hematology equipment. Use in this scenario focuses on consistency, quantitation, and biological reactivity, with material introduced during automated system calibration to verify EPO detection routine in clinical blood testing platforms. Each prefixed batch undergoes secondary verification in CLIA-certified labs for accuracy.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    5. Dialysis and Renal Care Centers: Routine Outpatient Medication Administration

    ESPOGEN Prefilled Inj. enters directly into outpatient renal therapy settings for immediate patient dosing. Medical staff utilize the controlled fill and sterile packaging to administer consistent erythropoietin injections pre- or post-dialysis, ensuring traceability from procurement through bedside delivery. The dosing protocol is tightly coordinated with patient hematologic monitoring and follows product-specific labeling and pharmacy oversight.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive ESPOGEN Prefilled Inj. prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618018036652 or mail to sales6@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618018036652

    Email: sales6@ascent-chem.com

    Inquiry

    Get Free Quote of LG Chem, Ltd

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Meet ESPOGEN Prefilled Injection: Consistency From the Manufacturer’s Bench

    Purpose-Built for Clinics and Hospitals

    Our facility produces ESPOGEN Prefilled Injection to support reliable anemia management in a variety of patient groups, especially those coping with chronic kidney disease or cancer therapies. Out on the manufacturing floor, we have seen the demands faced by healthcare professionals firsthand. Medical teams rely on medications that arrive ready-to-use, sparing them the uncertainty that can come from reconstitution or mixing errors. ESPOGEN Prefilled Injection arrives sterilized, dose-verified, and engineered for single-patient use, reducing room for cross-contamination or dosing inaccuracies. These strengths have become especially clear in busy dialysis wards and oncology outpatient units where time pressures and infection control matter just as much as treatment quality.

    Dosing, Presentation, and Model Options

    Within our injectable series, ESPOGEN Prefilled Injection stands out for its precision dosing and user-focused design. Our lines include common dose strengths, covering 2000 IU, 4000 IU, 6000 IU, and 10000 IU, each delivered in a clear, prefilled glass syringe. We run validation checks, not just on active ingredient content, but also on sterility and pH, so the experience remains predictable from batch to batch. Our machinery automates syringe fill volumes within strict tolerances, matching the common clinical dosing protocols doctors follow. Each syringe comes fitted with a fixed needle shield and leak-proof plunger, minimizing handling steps for nurses. In the last year, we adjusted our lot release specifications to improve ease of administration for practitioners, based directly on feedback from hospital groups using our product.

    Behind the Scenes at Our Production Line

    We do the blending, filling, sterilization, and final packaging all in-house. This integrated approach lets us control every process parameter, from raw material selection to fill-to-finish line environment. We purchase only human-compatible recombinant erythropoietin as the active molecule, sourced from qualified bio-reactors. You will not find us outsourcing validation or accepting gaps in cold chain tracking. Our environmental monitoring regime includes personnel and surface sampling, HEPA-filtered air, and particulate testing inside ISO 5 clean zones. Operators undergo recurring technique assessments to prevent even minor deviations in aseptic handling. By keeping these steps under our roof, our batches achieve tighter standardization compared to products pieced together by contract producers or distributors.

    Patient Safety: Built on Direct Manufacturing Control

    We have put patient safety at the center of production planning. Open an ESPOGEN Prefilled Injection, and you see the results: fixed-volume dosing, transparent labeling that displays batch and expiry, tamper-evident tray packaging, and zero need for manual dilution. We calibrate our fill lines twice per shift and trend sterility failures as part of a stringent deviation review. If anything falls outside our acceptance criteria, that lot does not reach pharmacies or clinics. Because we make and package each dose at the same location, temperature excursions or label mix-ups have not occurred in our line audits for several years running.

    Comparing Prefilled to Vial Formulations: Reducing Steps, Cutting Errors

    Vial formulations depend on correct draw-up and accurate dilution before each administration. Our staff field plenty of user questions about how much time hospitals lose each week tackling wasted doses or accidental needle pricks from multi-use vials. Switching to prefilled syringes offers a solution: care teams grab a dose matched to the patient’s needs and administer within minutes. Instead of juggling sterile water amps, disposable sharps, and extra paperwork, nurses and pharmacists focus on patient interaction and monitoring. For clinics running at full capacity, this time saving matters.

    Our prefilled model reduces the odds that vials are mislabelled, stored at the wrong temperature, or mixed up between shifts. Syringe package designs have color-coded dose indications and tamper-proof seals – not common in all injectable lines today. From manufacturing outflow to the end user, every step tracks back to our original fill record, a level of traceability not possible when bulk vials are divided on the ward.

    Formulation Stability and Cold Chain

    Manufacturers have seen what happens if the cold chain slips between our plant and the pharmacy. Active proteins like erythropoietin degrade if storage dips outside the 2–8°C window, even briefly. At our site, once we fill a batch of ESPOGEN Prefilled Injection, we move the trays into validated refrigerators and ship in temperature-controlled containers direct to licensed distributors. Data recorders ride with every pallet; if alarm thresholds trip, the shipment gets pulled for secondary assessment. In our audits, prefilled syringes fared better under transit stress and fewer temperature deviations made it back to our QA team compared to vials delivered in bulk. The compact, rugged nature of the ESPOGEN prefilled package enables clinics to stock up with confidence, knowing potency remains intact through storage and distribution.

    Helping Clinics Conserve Medication and Cut Waste

    Wasting injectable biologics places strain on hospital drug budgets and puts pressure on inventory availability for chronic patients. With single-use formats like ESPOGEN Prefilled Injection, every milliliter is allocated to a patient. Unlike multi-dose vials, partially used leftovers cannot be carried over or reused for another individual, sidestepping the temptation to overdraw or pool drugs between shifts. This direct-to-patient allocation has given our hospital partners tighter control over usage tracking and reduced expired returns. We ran a longitudinal review with three partner clinics and recorded dose wastage shrank by more than half following a rollout of the prefilled model. This outcome makes a difference as drug costs climb globally and payer audits demand accountability.

    Listening to End-User Feedback in Product Development

    Product tweaks at our plant arise from dialogue with medical professionals and pharmacists using ESPOGEN Prefilled Injection in real settings. When nurses flagged occasional hand discomfort during plunger actuation, our process engineering group prototyped new plunger geometry and grip textures. After trial runs, satisfaction scores jumped. Dose window clarity, carton opening resistance, plunger glide, even print layout on the primary label – we keep refining with their input. By having direct lines between the manufacturing floor and the healthcare setting, upgrades do not get bogged down by bureaucracy. Instead, practical changes go out to help clinics sooner. In the past year, we created a visual education leaflet inside each carton based on nurse training recommendations, making onboarding faster when new staff join high-turnover dialysis centers.

    Meeting Global Regulatory and Quality Benchmarks from Day One

    ESPOGEN Prefilled Injection passes through multiple quality gates before leaving our site. We operate a GMP-certified plant with full documentation from lot release down to recurrent raw material qualification. External auditors visit routinely and we maintain complete master formulas and SOPs. Our finished dose lines carry regulatory licenses for both domestic and international markets—a reflection of our early planning and investment in third-party batch qualification and bioidentity confirmation.

    Unlike trading houses or parallel importers who often chase the lowest bidder for fill and finish, we handle regulatory submissions and batch traceability directly. Testing for endotoxins, host cell protein, and particulate matter align with current health authority standards. This gives doctors, hospital decision makers, and patients peace of mind about the integrity and origin of their injectable treatment.

    Supporting Individualized Dosing and Treatment Flexibility

    Patients on erythropoiesis-stimulating agents often vary by age, body weight, and their response profile. Clinicians must titrate doses based on ongoing hemoglobin monitoring. By manufacturing ESPOGEN Prefilled Injection in several strengths, we support practitioners who want to optimize regimens with fewer dose holds or gaps between titrations. Our packaging lab has assisted hospitals to design in-house color guides and inventory bins, improving pick-and-pack efficiency for diverse outpatient rosters.

    For pediatric populations and patients shifting between hospital and home care, the matched syringe format helps families and caregivers administer medication with confidence. Doctors in our advisory network have noted lower rates of missed or delayed doses when prefilled styles replace vials, especially in remote or home treatment settings where trained pharmacists may not be on hand.

    Addressing Training and Administration Challenges

    Strong medication design reduces barriers to correct use, bridging the training gap for newer staff and supporting patient self-management off-site. From a manufacturing standpoint, we focus on building clarity and safety features right into the product. Tamper-evident seals, easy-read activity labels, and ergonomic grips on the plunger mean new hires spend less time on syringe handling and more on care delivery. Compared to classic vial-plus-syringe models, front-line users report greater comfort with visual confirmation of dose size and activity.

    During training seminars, our field support team often hears stories about how the reduction in handling steps with ESPOGEN Prefilled Injection enables earlier discharge and easier medication reconciliation. Reducing steps means less room for skipped checklist items in a high-throughput environment. In procedure simulations run by partner hospitals, error rates fell sharply after switching from vials to prefilled – improvement backed up in post-market surveillance data from our regulatory filings.

    Economic and Supply Chain Considerations

    By controlling the entire supply chain in-house, our operation has navigated both local and global market disruptions. Procurement costs stabilize, and we can respond quickly if hospital demand patterns change during epidemics, supply shortages, or policy shifts. Partner facilities do not pay markups to intermediaries and benefit from a direct vendor relationship for technical support or urgent orders. Maintaining direct distribution and short transport times preserves product freshness and reliability.

    Bulk purchasing of prefilled ESPOGEN Injection allows for simple stocktaking and fixed cost-per-dose calculations, aiding budget forecasts in public and private hospitals alike. Inventory rotations run smoother; expired stock diminishes compared to juggling half-empty vials nearing their end of life. Our logistics team tracks consignments to keep partners updated and ensure regulatory compliance across every location.

    Innovations from the Manufacturing Floor

    Continuous improvement drives our day-to-day operations as a manufacturer. Recent expansions in our plant focused on advanced filling robots and in-line quality vision systems, catching filling or labeling anomalies in real-time. Our QA team adopted real-time viability testing of air and surfaces in the fill suite, far beyond what most contract fillers implement. Investments in track-and-trace technology let us provide hospitals with digital documentation from batch origin through to dispensed dose. These measures raise standards across the injectable biologics segment—not just for our product line, but as a commitment to better patient experiences.

    Wastewater from cleaning cycles is treated on-site, avoiding impact on local water quality. Raw material procurement follows traceability protocols, so that every lot of active drug ties back to biosafe production lines. We participate in continuous knowledge-exchange with drug development researchers, updating product lines in response to new clinical practice guidelines or demand for more flexible dose forms.

    Addressing Remaining Industry Challenges

    While single-use, prefilled options bring advantages, cost concerns do crop up for some facilities. Upfront expense per syringe outpaces the unit cost of multi-dose vials. We address these conversations directly and show administrators that waste reduction, improved count control, and lower re-administration rates balance the initial investment. By highlighting the drop in adverse event investigations tied to dosing mistakes, clinics report fewer hidden costs in quality reviews and patient follow-up.

    Staff turnover and language differences sometimes create hesitancy around any new administration device. We supply demonstration units, on-site training, and phone support for practitioners new to ESPOGEN Prefilled Injection, allowing for smooth adoption in hospital and clinic settings. Research partners assist with localizing educational materials and sharing case reports that reinforce the safety and accuracy profile of prefilled units. We see first hand that hands-on training matters more than generic instruction sheets at ensuring safe and confident usage among varied staff groups.

    Commitment to Continuous Improvement

    As the pharmaceutical industry and medical community grow closer through data sharing and feedback loops, we view each batch of ESPOGEN Prefilled Injection as both a product and a responsibility. Our doors remain open to partnership, evaluation, and product upgrades based on practitioner and patient needs. By building each batch in a facility where every worker understands the importance of correct dosing, supply chain security, and safety, we commit to protecting health—even as treatment protocols and technologies evolve.

    What distinguishes ESPOGEN Prefilled Injection from others on the market does not come down to slogans or marketing. The difference comes from how we as manufacturers invest in batch control, clinical collaboration, and built-in safety, translating trust from our plant floor directly to the point of care. For us, it is never just a product on a shelf—each unit stands as proof of what it means to take manufacturing accountability seriously, support clinical workflow, and deliver reliable treatment to every patient, every time.